Cureety offers a certified telemonitoring platform for oncology that utilizes patient-reported outcome questionnaires to assess treatment-related symptoms and generate alerts for healthcare providers. This technology enhances patient care by enabling early detection of adverse effects, improving quality of life, and reducing emergency hospitalizations.
Funding
$5.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Oncology patients undergoing systemic treatments or radiotherapy often experience treatment-related side effects that can impact their quality of life and potentially lead to emergency hospitalizations. Detecting these adverse effects early and providing timely support is challenging with traditional in-person follow-up appointments alone.
Solution
Cureety offers a certified telemonitoring platform designed to improve the care pathway for oncology patients. The platform uses patient-reported outcome (PRO) questionnaires, delivered via a mobile app, tablet, or computer, to regularly assess treatment-related symptoms. An integrated algorithm analyzes patient responses based on CTCAE (Common Terminology Criteria for Adverse Events) standards to identify patients at risk. When the system detects a concerning symptom pattern, it generates alerts for healthcare providers and sends appropriate guidance and therapeutic advice to the patient. For patients unable to use the application, a module for telephone follow-up is available.
Target Audience
The primary users are healthcare professionals in oncology, including oncologists, nurses, and care coordinators, as well as hospitals and cancer centers looking to improve patient monitoring and outcomes.
Features
- Regular symptom assessment via patient-reported outcome (PRO) questionnaires tailored to specific cancer treatments and locations.
- Integration of the CTCAE (Common Terminology Criteria for Adverse Events) grading system for standardized symptom evaluation.
- Proprietary algorithm (Cureety TechCare) that analyzes patient responses and classifies their clinical status.
- Automated alerts to healthcare providers for patients classified as "critical" or "to be monitored."
- Patient-facing mobile application providing educational content and digital support for managing side effects.
- Module for telephone-based symptom reporting for patients who cannot or prefer not to use the application.
- "OK-Chimio" module to validate patient's condition prior to chemotherapy in the hospital.
- Secure data transmission and storage compliant with relevant data privacy regulations.